NovoCure (NASDAQ:NVCR) Price Target Raised to $20.00
NovoCure (NASDAQ:NVCR – Free Report) had its target price boosted by Evercore ISI from $14.50 to $20.00 in a research report released on Tuesday morning, Benzinga reports. Evercore ISI currently has an in-line rating on the medical equipment provider’s stock. A number of other brokerages have also recently weighed in on NVCR. Piper Sandler reaffirmed […]
More Stories
Trump Signs DHS Funding Bill, Ending Shutdown
By Jackson Richman and Joseph Lord President Donald Trump on April 30 signed legislation ending the Department of Homeland Security...
US Economy Rebounds With 2 Percent Growth in 1st Quarter
By Andrew Moran The U.S. economy registered a solid rebound in the first quarter after a disappointing end to 2025,...
Louisiana Governor Signals House Primaries Will Be Postponed After Supreme Court Redistricting Ruling
By Jacki Thrapp Louisiana plans to postpone U.S. House primaries in order to allow time for lawmakers to redraw and...
Top US General Signals Russia Is Helping Iran in War
By Jack Phillips The highest-ranking U.S. general on Thursday signaled that the Russian government is assisting the Iranian regime in...
Who is Chastity Nolan? Age, Husband, Children, and Social Media Updates
Have you watched videos of a mother-daughter duo while scrolling through your TikTok or Instagram account? That must be Chastity...
From Chaos to Control: How to Organize Your Life Like a Pro
Trying to stay organized, keeping on top of everything, from friends to family, social gatherings, events, and life admin, can...
